TPW
GILD icon

Transatlantique Private Wealth’s Gilead Sciences GILD Stock Holding History

Transatlantique Private Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$321K Sell
2,614
-81
-3% -$9.84K 0.1% 185
2025
Q3 		$299K Sell
2,695
-127
-5% -$14.4K 0.1% 194
2025
Q2 		$313K Sell
2,822
-21
-0.7% -$2.23K 0.12% 186
2025
Q1 		$319K Sell
2,843
-2,025
-42% -$209K 0.13% 180
2024
Q4 		$450K Sell
4,868
-4,626
-49% -$417K 0.17% 154
2024
Q3 		$796K Buy
9,494
+358
+4% +$27.3K 0.3% 102
2024
Q2 		$610K Buy
9,136
+70
+0.8% +$4.67K 0.25% 113
2024
Q1 		$664K Buy
9,066
+948
+12% +$72.9K 0.29% 116
2023
Q4 		$658K Sell
8,118
-30
-0.4% -$2.33K 0.31% 112
2023
Q3 		$611K Sell
8,148
-22
-0.3% -$1.69K 0.33% 101
2023
Q2 		$630K Buy
8,170
+689
+9% +$55K 0.33% 97
2023
Q1 		$621K Buy
7,481
+1,646
+28% +$136K 0.34% 94
2022
Q4 		$500K Sell
5,835
-2,866
-33% -$227K 0.3% 100
2022
Q3 		$538K Sell
8,701
-162
-2% -$10.2K 0.36% 94
2022
Q2 		$548K Buy
+8,863
New +$549K 0.38% 97

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Transatlantique Private Wealth's GILD Position: Q4 2025 in Review

Transatlantique Private Wealth reduced its Gilead Sciences (GILD) stake by 3% in Q4 2025, selling an estimated $9.84K and leaving 2,614 shares worth $321K. The position accounts for 0.1% of the portfolio, ranked #185.

Transatlantique Private Wealth first reported a position in GILD in Q2 2022 and has held it in 15 quarters since. The position peaked at $796K in Q3 2024. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Transatlantique Private Wealth held 2,614 shares of Gilead Sciences worth $321K as of Q4 2025.
  • Transatlantique Private Wealth sold 81 Gilead Sciences shares in Q4 2025, an estimated $9.84K.
  • Gilead Sciences made up 0.1% of Transatlantique Private Wealth's portfolio in Q4 2025, its #185 holding.
  • Transatlantique Private Wealth first reported a position in Gilead Sciences in Q2 2022 and has held it in 15 quarters since.
  • Transatlantique Private Wealth's Gilead Sciences position peaked at $796K in Q3 2024.
  • 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.